Recruiting
Acute Efficacy and 6 Months Follow up After Electroconvulsive Therapy
The overall aim of the current project is to assess the acute and long term outcome of ECT (both patient and clinician rated) in a non-selected patient cohort from ordinary clinical activity, and to seek out factors predicting response and remission, side effects and relapse.
ClinicalTrials.gov IDNCT05388461
PhaseNot Applicable
Enrollment600
SponsorHaukeland University Hospital
Age18 Years
SexALL
Conditions studied
Depressive Disorder
About this study
The overall aim of the current project is to assess the acute and long term outcome of ECT (both patient and clinician rated) in a non-selected patient cohort from ordinary clinical activity, and to seek out factors predicting response and remission, side effects and relapse.
Interventions
- Other: electroconvulsive therapy — electroconvulsive therapy
Primary outcomes
- Change of Montgomery and Åsberg Depression Rating Scale (MADRS) score from pretreatment at posttreatment; MADRS range 0 - 60, with higher scores indicating more severe depression) (up to 8 weeks)
- Change of Mini Mental State Examination (MMSE-NR) score from pretreatment at posttreatment; MMS-E range 0-30 with lower scores indicating more severe cognitive impairment (up to 8 weeks)
- Change of Beck depression inventory (BDI) score from pretreatment at posttreatment; BDI range 0-63, with higher scores indicating more severe depression (up to 8 weeks)
- Change of Everyday Memory Questionnaire (EMQ) score from pretreatment at posttreatment with higher scores indicating more severe impairment (up to 8 weeks)
Eligibility information
Inclusion Criteria:
* Patients treated with ECT for major depression (F31.3-5, F32, F33) at Haukeland University Hospital or Stavanger University Hospital after 2013,
* written consent to enrolment into the Regional Register for neurostimulation.
Exclusion Criteria:
* ECT performed on other indications than major depression.
* No consent to the register.
Study locations
- Haukeland University Hospital, Bergen, 5021 Norway
- Stavanger University Hospital, Stavanger, Norway
Before you participate: Varda Clinical is an independent discovery tool, not the study sponsor or a medical provider. Eligibility can only be determined by the official study team. Discuss potential risks and benefits with a qualified healthcare professional.
Source: ClinicalTrials.gov. Record last refreshed by Varda Clinical: 2026-09-27.